Carbamoyl phosphate synthetase I (EC
6.3.4.16) is the rate-limiting enzyme that catalyzes the first
committed step of the hepatic urea cycle. The mitochondrial isozyme
is designated CPS I and the cytoplasmic enzyme CPS II. CPS I catalyzes
the conversion of ammonia and bicarbonate to carbamyl phosphate. The
reaction requires a cofactor, N-acetylglutamate (NAG). Deficiency
of CPS1 causes an autosomal recessive urea cycle disorder that is
characterized by the triad of hyperammonemia, encephalopathy, and
respiratory alkalosis. Two forms of carbamoyl phosphate synthetase
deficiency are recognized: a lethal neonatal type and a less severe,
delayed-onset type. CPS1 is located at chromosome 2q35. The
gene contains 38 coding exons and encodes a polypeptide of 1500 amino
acid. To date, 20 different mutations have been reported, most of
thes are private mutations.
-
Confirmation of a clinical diagnosis
- Carrier testing
The exons and flanking intronic regions of the CPS1 gene
are PCR amplified and sequenced in the forward and reverse directions.
Blood: EDTA (purple-top)
tubes: Adult: 5
cc; Child & Infant: 3 cc
5
weeks
Index: 83891, 83904x76, 83898x38, 83912, 83894x2
Known Familial Mutation: 83904x4, 83898x2, 83912, 83891,
83894x2
>> Gene
Sequencing
Requisition or Mitochondrial
Requisition - Mitochondrial Diagnostic Checklist
is included
>> Prenatal
Requisition
Index: 3345
Known Familial Mutation: 3346
Prenatal: 3347
Last Modified: 5-2-08
|